1997
DOI: 10.1136/fn.77.1.f61
|View full text |Cite
|
Sign up to set email alerts
|

Use of methohexital for elective intubation in neonates

Abstract: The eVectiveness and safety of a short acting barbiturate, methohexital, was assessed for its use at the time of elective intubation in 18 newborn infants with severe respiratory or cardiac conditions. Evaluation included the speed of action and the degree of relaxation, sedation, and sleep in the first five minutes after administration. All newborn infants were intubated in a fully relaxed and somnolent state. In most infants recovery was completed within five minutes.A slight to moderate oxygen saturation dr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0
1

Year Published

2002
2002
2018
2018

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(31 citation statements)
references
References 33 publications
1
29
0
1
Order By: Relevance
“…In January 2013 the standard of care was changed to performing the INSURE procedure for the administration of surfactant in all infants with a gestational age ≥27 weeks and birth weight ≥750 g. As premedication for the INSURE procedure we started to use remifentanil. Remifentanil was administered intravenously as a fast bolus and followed by an intravenous saline flush in 30 s. After administration, the level of sedation was assessed with a standardized sedation score, performed by rubbing the sole of the patient's foot and judging the motor reaction to that stimulus (1 = spontaneous movement; 2 = movement on slight touch; 3 = movement in reaction to firm stimulus; 4 = no movement) [9]. In case of inadequate sedation (score 1 or 2), another dose of remifentanil was administered according to the protocol.…”
Section: Methodsmentioning
confidence: 99%
“…In January 2013 the standard of care was changed to performing the INSURE procedure for the administration of surfactant in all infants with a gestational age ≥27 weeks and birth weight ≥750 g. As premedication for the INSURE procedure we started to use remifentanil. Remifentanil was administered intravenously as a fast bolus and followed by an intravenous saline flush in 30 s. After administration, the level of sedation was assessed with a standardized sedation score, performed by rubbing the sole of the patient's foot and judging the motor reaction to that stimulus (1 = spontaneous movement; 2 = movement on slight touch; 3 = movement in reaction to firm stimulus; 4 = no movement) [9]. In case of inadequate sedation (score 1 or 2), another dose of remifentanil was administered according to the protocol.…”
Section: Methodsmentioning
confidence: 99%
“…43 In a small cohort study of term and preterm infants, methohexital facilitated intubation with rapid onset within 1 minute of sedation and recovery within 10 minutes. 44 However, more studies are necessary before methohexital can be recommended for use.…”
Section: Sedationmentioning
confidence: 99%
“…128 Methohexital in an uncontrolled study was associated with smooth intubating conditions and no apparent distress during intubation. 129 Studies on medications for use during endotracheal intubation are needed to address the requirements for analgesia, prevention of adverse physiologic responses (particularly bradycardia), and pharmacologic paralysis. This complex issue will be discussed further in a forthcoming statement from the American Academy of Pediatrics and Canadian Paediatric Society on the use of medications for elective intubation of neonates.…”
Section: Intubationmentioning
confidence: 99%